Le Lézard
Classified in: Health
Subjects: AWD, NPT, TRI

The Leukemia & Lymphoma Society Receives Significant Gift to Support Promising Young Scientists


RYE BROOK, N.Y., Oct. 10, 2018 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) continues to lead cutting-edge research to advance treatments for myeloma and lymphoma. Adding to the momentum, the organization today announced a $1,175,000 commitment by the Schwartz Ward Family Foundation (SWFF) of Chicago to support two unique research initiatives including a novel therapy for a rare form of lymphoma and an innovative immunotherapy approach for multiple myeloma.

These funds will support two grants in LLS's prestigious Career Development Program (CDP) ? offered to researchers early in their careers as incentive to encourage promising investigators to embark on scientific careers in the blood cancers. The two CDP grant recipients, both at City of Hope in Duarte, California, are:

Drs. Querfeld and Yu will be named "Schwartz Ward Family Foundation LLS Scholars."

The Schwartz Ward Family Foundation is led by Ted Schwartz, founding principal of Schwartz Capital Group in Chicago, and his children, Tracy Ward and Todd Schwartz. Ted Schwartz became aware of LLS's impact in blood cancer research through his friend, oncologist Steven Rosen, M.D., provost, chief scientific officer and director of the Irell & Manella Cancer Center at City of Hope National Medical Center. Dr. Rosen sits on the LLS Board of Directors.

"It is our hope that through our support of The Leukemia & Lymphoma Society's Career Development Program, this important research to be conducted by Drs. Querfeld and Yu will help lead to cures for these blood cancers and innovations in the blood cancer field that can inform cancer research across all forms," said Schwartz.

"LLS's research grants program is focused on identifying areas of critical unmet need and advancing the most cutting-edge research with the greatest promise of improving the lives of blood cancer patients," said Louis J. DeGennaro, Ph.D., LLS president and chief executive officer. "We are grateful to the Schwartz Ward Family Foundation for its generous commitment to supporting this important research and helping us advance the work of today's most talented young scientists."

About The Leukemia & Lymphoma Society 
The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to fighting blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care. Founded in 1949 and headquartered in Rye Brook, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET. For additional information visit lls.org/lls-newsnetwork. Follow us on FacebookTwitter, and Instagram.

Contact:

Linda Heaney

[email protected]

914-821-8208

SOURCE The Leukemia & Lymphoma Society


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: